Skip to main content

Table 6 Comparison of treatment outcome of active and subclinical tuberculosis diseases among all 420 enrolled participants

From: Clinical profiles of subclinical disease among pulmonary tuberculosis patients: a prospective cohort study in South Korea

 

Active TB disease (n = 339)

Subclinical TB disease (n = 81)

p value

Mortalitya

 Number (%)

26 (8.3%)

1 (1.2%)

0.025d

 OR (95% CI)

Reference

0.14 (0.02–1.04)

0.054

 Adjusted ORc (95% CI)

Reference

0.20 (0.03–1.55)

0.123

Treatment successb

 Number (%)

278 (82.0%)

71 (87.7%)

0.223d

 OR (95% CI)

Reference

0.64 (0.31–1.32)

0.226

 Adjusted ORc (95% CI)

Reference

0.74 (0.36–1.53)

0.412

  1. TB tuberculosis, OR odds ratio, CI confidence interval
  2. aIncidence of mortality during or before anti-TB treatment
  3. bSum of cured and treatment completed cases; For tuberculosis susceptible to both isoniazid and rifampicin, treatment success was determined within 1 year of anti-TB treatment. For tuberculosis resistant to either isoniazid or rifampicin, treatment success was determined during the treatment period regardless of duration
  4. cAdjusted by age and gender
  5. dChi-square test
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us